Trevena
| Region | Nordamerika |
| ISIN | US89532E1091 |
| Sektor | Biotechnologie |
| Website | http://www.trevena.com/ |
At Trevena, our mission is to deliver innovative solutions to patients and healthcare providers confronting serious medical conditions. Our history is rooted in strong science – Trevena was founded to translate Nobel Prize-winning research into a new generation of groundbreaking medicines. Our novel approach to drug discovery has established us as pioneers in acute care medicine.
| Titel | Datum |
|---|---|
| Your Daily Pharma Scoop: Gemphire Zooms, Trevena Succeeds, Arsanis Falters | vor 20 Tagen |
| Trevena shares pop on successful completion of Phase 1 study of acute migraine treatment | vor 23 Tagen |
| Trevena completes Phase 1 study of migraine treatment | vor 23 Tagen |
| Trevena Inc.: Trevena announces successful completion of Phase 1 study of TRV250 for acute migraine | vor 23 Tagen |
| Trevena files for $175M mixed shelf offering | vor ungefähr einem Monat |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| TrackX Holdings (1 Artikel) | |
| The Priceline Group (2 Artikel) | |
| United Internet (1 Artikel) | |
| Vapiano (2 Artikel) | |
| Alle anzeigen | |